Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 December 2013 6 december 2013NewsHumanPharmacovigilance PRAC considers benefits of Kogenate Bayer/Helixate NexGen outweigh risks in previously untreated patients 6 december 2013Press releaseHumanPharmacovigilance Further review of Iclusig started 6 december 2013Press releaseHumanPharmacovigilance European Medicines Agency applies greater fee-reduction rates for orphan medicines in 2014 3 december 2013NewsCorporateMedicines Regulatory information – adjustment of linguistic review timetable for opinions adopted at December CHMP meeting 2 december 2013NewsCorporate European Medicines Agency website unavailable Sunday 1 December 2013 29 november 2013NewsCorporateMedicines European Medicines Agency closed 23 December 2013 to 2 January 2014 29 november 2013NewsCorporateMedicines Early dialogue between regulators and health technology assessment bodies key to medicines development 28 november 2013Press releaseCorporate World AIDS Day 2013 – Revised guidance to facilitate development of new medicines 28 november 2013NewsCorporate European SME Week – early dialogue with the EMA is key to success 26 november 2013NewsCorporateSME 1 … 206 207 208 209 210 Page 210 of 380 211 212 213 214 … 380
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 December 2013 6 december 2013NewsHumanPharmacovigilance
PRAC considers benefits of Kogenate Bayer/Helixate NexGen outweigh risks in previously untreated patients 6 december 2013Press releaseHumanPharmacovigilance
European Medicines Agency applies greater fee-reduction rates for orphan medicines in 2014 3 december 2013NewsCorporateMedicines
Regulatory information – adjustment of linguistic review timetable for opinions adopted at December CHMP meeting 2 december 2013NewsCorporate
European Medicines Agency website unavailable Sunday 1 December 2013 29 november 2013NewsCorporateMedicines
European Medicines Agency closed 23 December 2013 to 2 January 2014 29 november 2013NewsCorporateMedicines
Early dialogue between regulators and health technology assessment bodies key to medicines development 28 november 2013Press releaseCorporate
World AIDS Day 2013 – Revised guidance to facilitate development of new medicines 28 november 2013NewsCorporate